Antigenics' researchers have shown that the Oncophage vaccine, which consists of the HSP-peptide complexes derived from a patient's tumor, interacts with the immune system's antigen-presenting cells at the site of injection. From this point on, the steps involved in triggering specific immune response appear to be the same as those triggered naturally when extracellular HSPs send a danger signal to the immune system. Specifically, the HSP complexes bind to the CD91 receptor on antigen-presenting cells (APCs), and are taken into the cells. The APCs then travel to the lymph nodes, where they re-present the antigenic peptides on their surfaces. This triggers a cancer-specific immune response, including stimulation of various immune cells and release of immune system chemicals called cytokines. More info at http://www.glioblastoma.it
Views:
5,765
Rating:
Comments
Is it same as dendritic cancer vaccine there also dendritic cells recognize cancer cell antigen here they are recognizing HSP protein?
No, it says that they are made for each individual person specifically.
Assumes no variation in cancer cells within a person?
good point, the cure is always in us, we just have to make sure that our body knows that there is something to repress
Del.icio.us
Digg
Facebook
StumbleUpon